C168 - Parkinson's Disease Update
Event Time: | Wednesday May 8, 2019 7:00 am to 9:00 am |
Topic(s): | Movement Disorders, Foundations in Clinical Neurology for APPs |
Director(s): | Melissa Nirenberg MD, PhD, FAAN |
Description: | This program will provide participants with a global overview of Parkinson's disease, including the latest information about pathophysiology, genetic and environmental risk factors, biomarkers, imaging, and clinical phenomenology. Faculty will also discuss current evidence-based management of motor symptoms, nonmotor symptoms, and complications of dopaminergic therapy, including the role of new and emerging medical and surgical treatments. |
Completion Message: | Participants should have a broad understanding of Parkinson's disease, including pathophysiology, genetics, biomarkers, risk factors, motor and nonmotor symptoms, complications of dopaminergic therapy, and evidence-based medical and surgical therapies. |
CME Credits: | 2 |
Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
Start/End Time | Title | Faculty |
---|---|---|
7:00 AM - 7:50 AM | Parkinson's Disease Update: Part I | Hubert H. Fernandez MD, FAAN |
7:50 AM - 8:00 AM | Questions and Answers | Hubert H. Fernandez MD, FAAN |
8:00 AM - 8:50 AM | Parkinson's Disease Update: Part II | Melissa J. Nirenberg MD, PhD, FAAN |
8:50 AM - 9:00 AM | Questions and Answers | Melissa J. Nirenberg MD, PhD, FAAN |
Speaker | Disclosure |
---|---|
Hubert H. Fernandez, MD, FAAN | Dr. Fernandez has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Prime Education Inc. International Parkinson and Movement Disorders Society, Carling Communications, Medscape, Vindico, AbbVie, Biogen, Blackthorn, Inventiv, Kyowa Hakko Kirin, Medscape, Voyager, Sunovion, and Pfizer Pharmaceuticals. Dr. Fernandez has received royalty, license fees, or contractual rights payments from Demos Publishing, Cambridge University Press. Dr. Fernandez has received research support from Abbvie, Biotie/Acorda Therapeutics, Michael J. Fox Foundation, Movement Disorders Society, NIH/NINDS, Parkinson Study Group, Rhythm, Sunovion. |
Melissa J. Nirenberg, MD, PhD, FAAN | Dr. Nirenberg has nothing to disclose. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C246 -
Hot Topics and Controversies in Parkinson's Disease
Melissa Nirenberg MD, PhD, FAAN |
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
1:00 PM-3:00 PM |
C253 -
Update in Movement Disorders
Alfonso Fasano MD, PhD |